Nov 14, 2023 / 03:00PM GMT
David Howard Windley - Jefferies LLC, Research Division - MD & Equity Analyst
Good morning. Welcome to Jefferies 2023 London Healthcare Conference. I'm pleased that you're able to be here and appreciate your attendance. My name is Dave Windley. I'm with Jefferies Equity Research in the States. I've run our small Nashville research office, and we do a fair amount of health care research out of that office.
Here with me today is West Pharmaceutical Services and management team, CEO, Eric Green and Head of Corporate Development, IR, Quintin Lai. We're very pleased to have you guys here. You're regular attenders at this meeting, and so thank you very much for being here and giving us your time.
Questions and Answers:
David Howard Windley - Jefferies LLC, Research Division - MD & Equity AnalystEric, I thought I'd just start us off with kind of a perspective question. West is kind of a pure play on the injectable drug space, the injectable drug space keeps getting hotter in general, but there have been a couple of really big bangs of COVID and
Trustpilot
